Germany’s Lucid Genomics secures €1.3M to advance AI-driven genetic insights for faster drug discovery
Berlin-based Lucid Genomics, a healthtech startup, has secured €1.3M in a pre-seed round of funding led by Caesar Ventures, with additional contributions from BIF Partners, Another.vc, and the MPF Accelerator Program.